Cleerly's Proxy solution improves heart disease imaging workflows
Cleerly introduces Proxy solution to improve heart disease imaging workflows Proxy allows for seamless data transmission and improved AI-based plaque...
Cleerly is aware of the lawsuit filed by Heartflow. We are confident in our extensive and well-established intellectual property portfolio and the originality of our technology.
Cleerly has published landmark clinical science that has redefined how cardiovascular disease is understood and treated, which has formed the basis of our novel technologies that provide physicians with actionable insights into their patients’ heart health.
Cleerly was founded on a mission to create a world without heart attacks, and we have never been more focused in our mission and committed to the patients and physicians who count on us.
For any questions, please reach out to press@cleerlyhealth.com
Cleerly introduces Proxy solution to improve heart disease imaging workflows Proxy allows for seamless data transmission and improved AI-based plaque...
Heart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care Hire follows Cleerly's $223 million Series C and furthers...
Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million High-profile investors led by T. Rowe Price and Fidelity back a new...
Organization recognizes venture-backed competitive companies championing innovation and creativity. New York, March 7, 2022 -- Cleerly, the company...